Get the Stockscreener App
0.00
100.00%
-7.04
180 Life Sciences Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
See More
Previous Close:
$7.04
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
0.00
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
Will breakout in 180 Life Sciences Corp. Equity Warrant lead to full recoveryWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Intraday pattern recognizer results for 180 Life Sciences Corp. Equity WarrantWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - newser.com
Will 180 Life Sciences Corp. stock remain a Wall Street favoriteJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Advanced analytics toolkit walkthrough for 180 Life Sciences Corp. Equity WarrantEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
Will 180 Life Sciences Corp. stock continue upward momentum2025 Institutional Moves & Detailed Earnings Play Strategies - newser.com
How to integrate 180 Life Sciences Corp. into portfolio analysis toolsEntry Point & Verified Short-Term Plans - newser.com
Will 180 Life Sciences Corp. benefit from macro trendsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Sector ETF performance correlation with 180 Life Sciences Corp.Weekly Trade Analysis & Stock Portfolio Risk Management - newser.com
When is the best time to exit 180 Life Sciences Corp. Equity WarrantEarnings Overview Report & Safe Investment Capital Preservation Plans - newser.com
180 Life Sciences Corp. Equity Warrant’s volatility index tracking explained2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Using portfolio simulators with 180 Life Sciences Corp. Equity Warrant includedJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Using fundamentals and technicals on 180 Life Sciences Corp.Weekly Profit Report & AI Powered Market Trend Analysis - newser.com
Key metrics from 180 Life Sciences Corp. Equity Warrant’s quarterly dataJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Historical volatility pattern of 180 Life Sciences Corp. Equity Warrant visualizedOptions Play & Step-by-Step Trade Execution Guides - newser.com
How institutional buying supports 180 Life Sciences Corp. Equity Warrant stockPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Risk vs reward if holding onto 180 Life Sciences Corp.2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
What high frequency data says about 180 Life Sciences Corp.Index Update & Fast Momentum Entry Tips - newser.com
Is a relief rally coming for 180 Life Sciences Corp. Equity Warrant holders2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Key resistance and support levels for 180 Life Sciences Corp.July 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
News impact scoring models applied to 180 Life Sciences Corp. Equity WarrantWeekly Trade Summary & Reliable Intraday Trade Plans - newser.com
What does recent volatility data suggest for 180 Life Sciences Corp. Equity WarrantPortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Is 180 Life Sciences Corp. Equity Warrant a candidate for recovery playWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Combining machine learning predictions for 180 Life Sciences Corp.Quarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Is now a turning point for 180 Life Sciences Corp.July 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
Price momentum metrics for 180 Life Sciences Corp. Equity Warrant explainedJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Using Bollinger Bands to evaluate 180 Life Sciences Corp.July 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Can 180 Life Sciences Corp. Equity Warrant stock outperform in 2025 bull marketPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
How to read the order book for 180 Life Sciences Corp. Equity WarrantCEO Change & Consistent Growth Equity Picks - newser.com
Heatmap analysis for 180 Life Sciences Corp. Equity Warrant and competitors2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
What the charts say about 180 Life Sciences Corp. Equity Warrant todayChart Signals & Comprehensive Market Scan Reports - newser.com
What drives 180 Life Sciences Corp Equity Warrant stock priceStock Watchlist Updates & Free Trading Psychology Sessions - earlytimes.in
Is 180 Life Sciences Corp a good long term investmentCapital Gains Strategies & Minimal Capital Growth Plans - earlytimes.in
How to build a dashboard for 180 Life Sciences Corp. Equity Warrant stockTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
What analysts say about 180 Life Sciences Corp Equity Warrant stockSupport Zone Identification & Free Tools to Find Winning Stocks - earlytimes.in
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
180 Life Sciences Corp Stock (ATNF) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ELRAY RESOURCES, INC. | Former 10% Owner |
Jul 27 '25 |
Sale |
3.00 |
1,680,000 |
5,040,000 |
2,638,000 |
| ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 08 '25 |
Sale |
3.18 |
777,595 |
2,472,752 |
1,725,148 |
| ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 11 '25 |
Sale |
3.17 |
405,148 |
1,284,319 |
1,320,000 |
| ELRAY RESOURCES, INC. | Former 10% Owner |
Aug 07 '25 |
Sale |
3.56 |
135,257 |
481,515 |
2,502,743 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):